
Friday, June 13, 2025 4:01:58 PM
Andrew Caravello wrote on X this morning (and thanks to Eagle8 for posting it over here) how Dr. Crystal Mackall who
discovered how IL-7, a natural protein in the body, helps rebuild and strengthen the immune system
This is what Andrew wrote about it:
IL-7 Already Complements DCVax-L
IL-7—specifically the clinical-grade version called CYT107, developed and patented by RevImmune—is like fuel for your immune system. It helps T-cells grow back after chemo, stay diverse, and remember what they’ve been trained to attack.
That encouraged me to reacquaint myself with IL-7. This is what Google's AI said:
Interleukin-7 (IL-7) is a cytokine that plays a crucial role in regulating the development, survival, and proliferation of various immune cells, particularly B cells, T cells, and NK cells. It's essential for the proper function of the immune system, and deficiencies in IL-7 can lead to severe immunodeficiency.
Here's a more detailed look at what IL-7 does:
1. B Cell Development and Homeostasis:
IL-7 is critical for the development of B cells, specifically promoting the progression of B-cell progenitors from the pre-pro-B-cell stage to later stages.
It promotes the proliferation and survival of B cells, as well as the upregulation of cell cycle regulators like cyclin D3.
IL-7 also plays a role in the rearrangement of immunoglobulin genes in precursor B cells.
2. T Cell Development and Homeostasis:
IL-7 is essential for the survival and expansion of T cells, especially naive T cells and memory T cells.
It regulates the balance between proliferation and apoptosis in T cells.
IL-7 can also promote T cell survival by upregulating anti-apoptotic genes like Bcl-2 and Mcl-1.
3. Other Immune Cells:
IL-7 is involved in the development and function of other immune cells, including natural killer (NK) cells and dendritic cells.
It contributes to the activation of immune cells in anti-virus and anti-tumor immunity.
4. Role in Immunity and Disease:
IL-7 is involved in regulating the immune system's response to infections and tumors.
IL-7 therapy has shown promise in improving immune reconstitution after certain treatments, such as antiretroviral therapy for HIV infection.
IL-7 can also be used as a molecular adjuvant to improve vaccine efficacy by promoting and extending systemic immune responses.
IL-7's role in immune regulation also extends to its potential involvement in autoimmune diseases, where it can contribute to T cell-driven autoimmunity.
In summary, IL-7 is a versatile cytokine with a wide range of functions related to immune cell development, homeostasis, and the overall immune response. Its role in maintaining a healthy immune system makes it a target for research and therapeutic interventions, especially in conditions like immunodeficiency, autoimmune diseases, and cancer.
I very much appreciate your work, dstock.

Recent NWBO News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
- Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments • AllPennyStocks.com • 01/13/2025 01:56:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 10:07:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:29:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM